Mantini Giulia, Meijer Laura L, Glogovitis Ilias, In 't Veld Sjors G J G, Paleckyte Rosita, Capula Mjriam, Le Large Tessa Y S, Morelli Luca, Pham Thang V, Piersma Sander R, Frampton Adam E, Jimenez Connie R, Kazemier Geert, Koppers-Lalic Danijela, Wurdinger Thomas, Giovannetti Elisa
Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), 1081 HV Amsterdam, The Netherlands.
Fondazione Pisana per la Scienza, 56017 Pisa, Italy.
Cancers (Basel). 2020 Dec 29;13(1):66. doi: 10.3390/cancers13010066.
Pancreatic ductal adenocarcinoma (PDAC) is traditionally associated with thrombocytosis/hypercoagulation and novel insights on platelet-PDAC "dangerous liaisons" are warranted. Here we performed an integrative omics study investigating the biological processes of mRNAs and expressed miRNAs, as well as proteins in PDAC blood platelets, using benign disease as a reference for inflammatory noise. Gene ontology mining revealed enrichment of RNA splicing, mRNA processing and translation initiation in miRNAs and proteins but depletion in RNA transcripts. Remarkably, correlation analyses revealed a negative regulation on SPARC transcription by isomiRs involved in cancer signaling, suggesting a specific "education" in PDAC platelets. Platelets of benign patients were enriched for non-templated additions of G nucleotides (#ntaG) miRNAs, while PDAC presented length variation on 3' (lv3p) as the most frequent modification on miRNAs. Additionally, we provided an actionable repertoire of PDAC and benign platelet-ome to be exploited for future studies. In conclusion, our data show that platelets change their biological repertoire in patients with PDAC, through dysregulation of miRNAs and splicing factors, supporting the presence of protein machinery that can "educate" the platelet. These novel findings could be further exploited for innovative liquid biopsies platforms as well as possible therapeutic targets.
胰腺导管腺癌(PDAC)传统上与血小板增多症/高凝状态相关,因此有必要对血小板与PDAC之间的“危险关系”进行新的深入研究。在这里,我们进行了一项综合组学研究,以良性疾病作为炎症干扰的对照,调查了PDAC患者血小板中mRNA、表达的miRNA以及蛋白质的生物学过程。基因本体挖掘显示,miRNA和蛋白质中RNA剪接、mRNA加工和翻译起始过程富集,但RNA转录本中这些过程减少。值得注意 的是,相关性分析显示,参与癌症信号传导的isomiR对SPARC转录有负调控作用,这表明PDAC血小板存在特定的“驯化”现象。良性患者的血小板富含非模板化添加G核苷酸(#ntaG)的miRNA,而PDAC患者血小板中miRNA最常见的修饰是3'端长度变异(lv3p)。此外,我们提供了一份可用于未来研究的PDAC和良性血小板组信息清单。总之,我们的数据表明,PDAC患者的血小板通过miRNA和剪接因子的失调改变了其生物学特性,支持了能够“驯化”血小板的蛋白质机制的存在。这些新发现可进一步用于创新液体活检平台以及可能的治疗靶点。